The first generation of CSF biomarkers for Alzheimer disease comprises those that measure the component proteins of the disease’s signature pathologic lesions. They have been explored for almost 15 ...
CSF oligoclonal bands is a test ordered by physicians when serious health concerns related to your central nervous system arise. Here’s what you need to know about it. If your physician suspects ...
Roche announced June 27 that the U.S. FDA has issued 510(k) clearance for the company's CSF Aβ42/total-tau assay to be used for the diagnosis of Alzheimer’s disease in people aged 55 and older. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback